SCHEMBL23651305

SCHEMBL23651305

COc1cc2c(cc1C(=O)Nc1cccc(C(C)(C)C)c1)CCCCC2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.77
▸ LMNA P02545 3/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ MAPK14 Q16539 3/20 0.53
▸ RXFP1 Q9HBX9 2/20 0.51
▸ RAB9A P51151 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ P2RX1 P51575 1/20 0.49
▸ NR1H4 Q96RI1 1/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ KCNK3 O14649 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090382 0.87 DHODH (1.00) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090367 0.81 DHODH (1.00) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23105163 0.78 DHODH (0.79) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090416 0.78 DHODH (1.00) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090412 0.78 DHODH (0.71) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090371 0.78 DHODH (0.71) DHODHLMNASMN1; SMN2MAPTHTT
SCHEMBL21468491 0.77 DHODH (0.79) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090379 0.76 DHODH (0.78) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090411 0.76 DHODH (0.71) DHODHLMNASMN1; SMN2MAPTALDH1A1
SCHEMBL23090385 0.75 DHODH (0.70) DHODHLMNASMN1; SMN2RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885LMNA 3202/4885SMN1; SMN2 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback